Safety and Efficacy of a Novel Calcium Sensitizer, Levosimendan, in Patients With Left Ventricular Failure due to an Acute Myocardial Infarction - RUSSLAN

Description:

This was a randomized, double-blind, placebo-controlled trial of levosimendan, an intravenous calcium sensitizer, in patients with left ventricular failure after acute myocardial infarction (AMI).